Private Advisor »

Atara Biotherapeutics shares owned by Private Advisor

Quarter-by-quarter ownership of Atara Biotherapeutics (ATRA) shares owned by Private Advisor from 13F filings

Historical chart of Private Advisor investment in Atara Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atara Biotherapeutics held by Private Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atara Biotherapeutics by Private Advisor

Quarter filed Position value Share count Share price at filing
2023-12-31 $49k 96k 0.51
2023-09-30 $141k 96k 1.48
2023-06-30 $101k 62k 1.61

More positions owned by Private Advisor

Apple (AAPL)
Vanguard Index Fds Total Stk Mkt (VTI)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Spdr Ser Tr Portfoli S&p1500 (SPTM)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Select Sector Spdr Tr Technology (XLK)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Spdr Ser Tr Portfolio Agrgte (SPAB)

View all positions for Private Advisor

Top funds holding Atara Biotherapeutics

EcoR1 Capital
Redmile Group
Vanguard Group
UBS Group
AQR Capital Management
Millennium Management
Jpmorgan Chase & Co
D. E. Shaw & Co
Staley Capital Advisers
GSA Capital Partners
Jacobs Levy Equity Management
Charles Schwab Investment Management
Goldman Sachs Group
Bank of New York Mellon
Bnp Paribas Arbitrage, Snc

View all funds holding Atara Biotherapeutics